PSMAddition: A phase 3 trial to compare treatment with 177 Lu-PSMA-617 plus standard of care (SoC) and SoC alone in patients with metastatic hormone-sensitive prostate cancer.

Details

Language :

English

ISSN :

0732183X

Volume :

41

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

164018286

Full Text :

https://doi.org/10.1200/JCO.2023.41.16_suppl.TPS5116